Technologically-Treated Polyclonal Affinity-Purified Antibodies to the Tumor Necrosis Factor-α, Brain Specific S-100 Protein and Histamine in Treatment of Functional Dyspepsia: Results of the Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Technologically-Treated Polyclonal Affinity-Purified Antibodies to the Tumor Necrosis Factor-α, Brain Specific S-100 Protein and Histamine in Treatment of Functional Dyspepsia: Results of the Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

The aim of the study was to evaluate the efficacy and safety of Kolofort® (a complex medicine containing technologically processed forms of antibodies to S-100 protein, tumor necrosis factor-α and histamine) in the management of functional dyspepsia (FD) in outpatient clinical practice.Methods: Outp...

Full description

Bibliographic Details
Main Authors: Yu. O. Shulpekova, I. V. Maev, V. B. Grinevich, I. B. Khlynov, Yu. G. Shvarts, V. T. Ivashkin
Format: Article
Language:Russian
Published: Gastro LLC 2022-09-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
functional dyspepsia
placebo-controlled trial
technologically-treated polyclonal affinity-purified antibodies to the tumor necrosis factor-α
brain specific s-100 protein and histamine
efficacy assessment
safety profile
Online Access:https://www.gastro-j.ru/jour/article/view/743

Internet

https://www.gastro-j.ru/jour/article/view/743

Similar Items